EpiEffect™
The Science Behind EpiEffect™ EpiEffect™, an innovative tri-layer human placental allograft developed by MiMedx, represents a significant advancement in the field of wound care management. Designed to address both acute and chronic wounds, EpiEffect™ utilizes a lyophilized membrane that includes the amnion, intermediate, and chorion layers. This unique structure provides a protective barrier that supports […]
Intro to Revenue Cycle in Advanced Wound Care
Maximizing Efficiency in Wound Care Revenue Cycle Management (RCM) In the rapidly evolving healthcare industry, advanced wound care stands out, requiring both clinical expertise and skilled revenue cycle management (RCM). Organizations like WoundGenex are leading the way, seamlessly integrating superior wound care services with effective RCM strategies. This in-depth analysis highlights the pivotal role of […]
WOUNDGENEX PARTNERS WITH MIMEDX TO LAUNCH PREMIER GRAFT PROGRAM TO WOUND CARE PROVIDERS NATIONWIDE
Tampa, FL – March 16th , 2022, Leading wound care management and clinical services provider, WoundGenex, today announced a strategic partnership with MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX”), a transformational placental biologics company, to launch an exclusive version of WoundGenex’s Premier Graft Program to its clients across the country, providing clinicians access to industry-leading allograft […]